Daina Graybosch analyst

Currently out of the existing stock ratings of Daina Graybosch, 115 are a BUY (80.42%), 26 are a HOLD (18.18%), 2 are a SELL (1.4%).

Daina Graybosch

Work Performance Price Targets & Ratings Chart

Analyst Daina Graybosch, carries an average stock price target met ratio of 29.94% that have a potential upside of 39.86% achieved within 176 days. Previously, Daina Graybosch worked at LEERINK.

Daina Graybosch’s has documented 262 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on MRK, Merck mpany at 09-Sep-2026.

Wall Street Analyst Daina Graybosch

Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS ) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.

Average potential price target upside

ACLX Arcellx BNTX BioNTech SE FATE Fate Therapeutics MRK Merck mpany SBTX Silverback Therapeutics  AFMD Affimed NV CGEN Compugen IPHA Innate Pharma IPSC Century Therapeutics ITOS Iteos Therapeutics  MOLN Molecular Partners AG ADR NKTR Nektar Therapeutics BOLT Bolt Biotherapeutics FSTX FStar Therapeutics HOWL Werewolf Therapeutics LVTX LAVA Therapeutics NV TSVT 2Seventy Bio RCUS Arcus Biosciences KDNY Chinook Therapeutics ADRO Aduro Biotech ADAG Adagene GNCA Genocea Biosciences IT Gartner SB Safe Bulkers SMMT Summit Therapeutics PLC XLO Xilio Development

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2022

$115

$-0.07 (-0.06%)

6 months 21 days ago
(26-Feb-2026)

2/2 (100%)

$1.12 (0.98%)

110

Buy Since 24-Feb-2026

$115

$-0.07 (-0.06%)

$85

6 months 23 days ago
(24-Feb-2026)

2/2 (100%)

$1.25 (1.10%)

90

Buy Since 20-Jun-2023

$120

$4.93 (4.28%)

$136

6 months 23 days ago
(24-Feb-2026)

4/6 (66.67%)

$6.25 (5.49%)

192

Buy Since 01-Mar-2022

$115

$-0.07 (-0.06%)

$39

6 months 23 days ago
(24-Feb-2026)

9/9 (100%)

$1.25 (1.10%)

279

Buy Since 17-Jun-2025

$115

$-0.07 (-0.06%)

$110

6 months 23 days ago
(24-Feb-2026)

2/2 (100%)

$1.25 (1.10%)

151

Show more analysts

Please expand the browser size to see the chart

Which stock is Daina Graybosch most bullish on?

Potential upside of $17.07 has been obtained for MRK (MERCK MPANY)

Which stock is Daina Graybosch most reserved on?

Potential downside of -$4.55 has been obtained for SMMT (SUMMIT THERAPEUTICS PLC)

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?